| Předmět: |
|
| Zdroj: |
Cardiovascular Week; 2024, p1088-1088, 1p |
| Abstrakt: |
A recent report from researchers at Fujian Medical University in China explores the relationship between gut microbiota and cardiovascular disease, specifically atherosclerosis. The study aims to understand how gut microbiota and its metabolites contribute to the formation of vulnerable atherosclerotic plaque and the impact on plaque stability. The researchers suggest that regulating gut microbiota could potentially lower the morbidity rate of myocardial infarction by reducing the formation of vulnerable plaque. This research provides a new perspective on the therapeutic direction for coronary heart disease. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
